MARGARET ODURO: Open Payments
NPI 1417443367 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,310 in 16 payments from 7 companies in 2025. Trend: 2023 $14 · 2024 $410 · 2025 $1,310
Food & beverage: $1,310
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $316 |
| Janssen Pharmaceuticals, Inc | 4 | $288 |
| ABBVIE INC. | 2 | $238 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Alkermes, Inc. | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $120 |
| Alnylam Pharmaceuticals Inc. | 1 | $101 |
Products named: VRAYLAR, REXULTI, INVEGA SUSTENNA, ABILIFY MAINTENA, Auvelity, LYBALVI, UZEDY, INVEGA TRINZA.
Industry payments across PA — which companies pay providers there.
